Sio Capital Management, LLC Elevation Oncology, Inc. Transaction History

Sio Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.75 - $2.55 $387,660 - $1.32 Million	516,880 Added 143.69%	876,611 $1.67 Million
Q1 2022 May 16, 2022	BUY	$2.34 - $6.41 $256,770 - $703,375	109,731 Added 43.89%	359,731 $907,000
Q4 2021 Feb 14, 2022	BUY	$4.15 - $8.86 $1.04 Million - $2.22 Million	250,000 New	250,000 $1.51 Million

45.4M

700

27.6K

Ticker ELEV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,300,900
Market Cap $15.1M
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.